Application | Comment | Organism |
---|---|---|
molecular biology | beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl and other nitrophenyl-sugar-derivatives are useful as specific inhibitors and as affinity label | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | and other nitrophenyl-sugar-derivatives; strong inhibition under UV-radiation at 350 nm, specific for substrate binding site, preincubation with beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl partially protects | Homo sapiens | |
substrate analogues lacking the 6-hydroxyl of the N-acetylgalactosamine | weak | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Homo sapiens | - |
- |
microsome | - |
Rattus norvegicus | - |
- |
microsome | - |
Sus scrofa | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Rattus norvegicus | - |
? | - |
? | |
additional information | Sus scrofa | - |
? | - |
? | |
additional information | Homo sapiens | enzyme activity is increased in patients with chronic myelogenous leukemia CML or acute myeloid leukemia AML | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Sus scrofa | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
acute myeloid leukemia cell | acute myeloid leukemia blast cell line | Homo sapiens | - |
colon | - |
Homo sapiens | - |
colon | - |
Rattus norvegicus | - |
colon | - |
Sus scrofa | - |
gastric mucosa | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | - |
Rattus norvegicus | ? | - |
? | |
additional information | - |
Sus scrofa | ? | - |
? | |
additional information | enzyme activity is increased in patients with chronic myelogenous leukemia CML or acute myeloid leukemia AML | Homo sapiens | ? | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Homo sapiens | ? | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | ? | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | ? | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? | |
UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | inhibitory under UV-radiation | Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? |